Neha S Shah, MD
Rheumatology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Community Hospital of the Monterey Peninsula · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shah’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A77436 · Current
Licensed to practise in California · since 2015 · expires 2028-09-30 · University of Florida College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036119828Licensed Physician And Surgeon · since 2007 · expires 2017-07-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$43,544
Medicare paid this office $43,544 for 165 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 104 | $18,824 | $114 |
| Long return visit (40+ min) | 33 | $8,025 | $164 |
| Short return visit (20+ min) | 48 | $5,085 | $83 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 122 | $3,289 | $15 |
| New patient visit (60+ min) | 17 | $3,237 | $190 |
See all 6 services
| Return visit (30+ min) | 104 | $18,824 | $114 |
| Long return visit (40+ min) | 33 | $8,025 | $164 |
| Short return visit (20+ min) | 48 | $5,085 | $83 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 122 | $3,289 | $15 |
| New patient visit (60+ min) | 17 | $3,237 | $190 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 11 | $165 | $15 |
Who their Medicare patients are
165 Original Medicare patients in 2024. Average age 71 · Women 71% · Also on Medicaid 23% · Health risk score 1.64. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 67% · Coronary heart disease 33% · Chronic kidney disease 29% · Diabetes 28% · Depression 21% · Cancer 18% · Atrial fibrillation 18% · Heart failure 17% · COPD 13% · Stroke 8%.
The office billed $246,648, Medicare allowed $57,942 and paid $43,544; for 604 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 165 | 604 | 71 | 1.64 | $246,648 | $43,544 |
| 2023 | 172 | 384 | 70 | 2.03 | $238,468 | $34,659 |
| 2022 | 119 | 293 | 70 | 1.72 | $159,592 | $22,775 |
| 2021 | 146 | 328 | 69 | 1.69 | $181,172 | $30,180 |
| 2020 | 117 | 309 | 68 | 2.01 | $165,404 | $24,464 |
| 2019 | 101 | 216 | 69 | 2.02 | $117,952 | $20,750 |
| 2018 | 90 | 173 | 69 | 1.54 | $64,628 | $16,598 |
| 2017 | 91 | 186 | 69 | 1.92 | $74,388 | $18,710 |
| 2016 | 76 | 164 | 69 | 1.45 | $50,645 | $14,927 |
| 2015 | 40 | 76 | 70 | 1.84 | $26,939 | $8,114 |
| 2014 | 169 | 316 | 72 | 1.27 | $42,180 | $18,577 |
| 2013 | 224 | 687 | 72 | 1.23 | $85,133 | $37,556 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 76 | $9,255 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $4,958 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,717 | $110 |
| Return visit (30+ min) | 33 | $4,692 | $109 |
| Short return visit (20+ min) | 33 | $1,841 | $50 |
| Long return visit (40+ min) | 12 | $1,729 | $133 |
| Telehealth originating site facility fee | 14 | $348 | $20 |
2022: 5 services
| Return visit (30+ min) | 53 | $7,389 | $83 |
| Return visit (30+ min) | 26 | $4,289 | $116 |
| Short return visit (20+ min) | 34 | $2,629 | $51 |
| Short return visit (20+ min) | 17 | $1,306 | $73 |
| Telehealth originating site facility fee | 25 | $588 | $20 |
2021: 6 services
| Return visit (30+ min) | 68 | $9,045 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $3,627 | $95 |
| Short return visit (20+ min) | 44 | $3,296 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,591 | $185 |
| Return visit (30+ min) | 17 | $2,121 | $118 |
| Telehealth originating site facility fee | 14 | $303 | $22 |
2020: 7 services
| Return visit (30+ min) | 60 | $8,191 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,865 | $191 |
| Return visit (30+ min) | 33 | $2,570 | $71 |
| Long return visit (40+ min) | 12 | $1,606 | $124 |
| Telehealth originating site facility fee | 53 | $1,361 | $21 |
| Short return visit (20+ min) | 24 | $1,162 | $46 |
| Short return visit (20+ min) | 11 | $782 | $71 |
2019: 4 services
| Return visit (30+ min) | 61 | $8,146 | $87 |
| New patient visit (60+ min) | 24 | $3,886 | $162 |
| Long return visit (40+ min) | 20 | $3,704 | $119 |
| Return visit (30+ min) | 15 | $1,032 | $65 |
2018: 3 services
| Long return visit (40+ min) | 57 | $8,623 | $98 |
| New patient visit (60+ min) | 28 | $4,038 | $144 |
| Return visit (30+ min) | 23 | $2,213 | $76 |
2017: 3 services
| Long return visit (40+ min) | 38 | $7,518 | $103 |
| New patient visit (60+ min) | 30 | $4,731 | $158 |
| Return visit (30+ min) | 19 | $1,741 | $73 |
2016: 4 services
| Long return visit (40+ min) | 35 | $4,731 | $89 |
| New patient visit (60+ min) | 29 | $4,329 | $149 |
| Return visit (30+ min) | 18 | $2,174 | $66 |
| New patient visit (45+ min) | 11 | $1,154 | $105 |
2015: 1 service
| New patient visit (60+ min) | 16 | $2,404 | $150 |
2014: 5 services
| Return visit (30+ min) | 105 | $8,416 | $58 |
| Long return visit (40+ min) | 28 | $3,412 | $87 |
| Aspiration and/or injection of fluid from large joint | 34 | $2,088 | $44 |
| Short return visit (20+ min) | 43 | $1,637 | $33 |
| New patient visit (45+ min) | 11 | $1,119 | $102 |
2013: 6 services
| Return visit (30+ min) | 161 | $18,109 | $59 |
| Aspiration and/or injection of fluid from large joint | 45 | $4,472 | $35 |
| New patient visit (45+ min) | 39 | $3,957 | $101 |
| Short return visit (20+ min) | 71 | $3,615 | $38 |
| Long return visit (40+ min) | 17 | $2,131 | $82 |
| Short return visit | 15 | $355 | $19 |
Medicaid work
$2,835 in 2023
Medicaid paid $2,835 for 68 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 42 | $1,732 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $1,103 |
| 2023 | 68 | 2 | 15 | $2,835 |
Drugs they prescribed that Part D paid
$959,700
Pharmacies billed $959,700 in 2024. Most of that is one immune-globulin drugs at about $19,000 a fill for a small number of people.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 581) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
463 generic and fewer than 11 brand-name prescriptions · $959,700 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Privigen | Immune globulin | 13 | $251,568 | $19,351 |
| Humira | None | 11 | $83,694 | $7,609 |
| Rinvoq | None | 13 | $83,153 | $6,396 |
| Mycophenolate Mofetil | None | 27 | $4,986 | $185 |
| Hydroxychloroquine Sulfate | None | 42 | $2,853 | $68 |
See all 13 drugs
| Privigen | Immune globulin | 13 | $251,568 | $19,351 |
| Humira | None | 11 | $83,694 | $7,609 |
| Rinvoq | None | 13 | $83,153 | $6,396 |
| Mycophenolate Mofetil | None | 27 | $4,986 | $185 |
| Hydroxychloroquine Sulfate | None | 42 | $2,853 | $68 |
| Methotrexate | None | 102 | $2,786 | $27 |
| Leflunomide | None | 23 | $1,523 | $66 |
| Prednisone | None | 93 | $1,349 | $15 |
| Duloxetine | None | 21 | $426 | $20 |
| Methotrexate | None | 22 | $338 | $15 |
| Folic Acid | None | 14 | $206 | $15 |
| Allopurinol | None | 26 | $163 | $6 |
| Methylprednisolone | None | 17 | $99 | $6 |
Year by year
| 2024 | 581 | 108 | 0% (0) | None | $959,700 |
| 2023 | 579 | 97 | None | None | $683,487 |
| 2022 | 582 | 75 | None | None | $617,010 |
| 2021 | 588 | 86 | None | None | $548,370 |
| 2020 | 653 | 85 | None | 19% | $421,727 |
| 2019 | 612 | 73 | None | None | $362,347 |
| 2018 | 641 | 66 | None | None | $306,360 |
| 2017 | 588 | 66 | None | None | $170,685 |
| 2016 | 453 | 57 | None | None | $77,141 |
| 2015 | 168 | 47 | None | 20% | $18,585 |
| 2014 | 793 | 141 | 7% (55) | 28% | $140,465 |
| 2013 | 1,080 | 147 | 11% (114) | None | $148,950 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Xeljanz | 27 | $177,469 | $6,573 |
| Humira | 19 | $142,880 | $7,520 |
| Cimzia | 12 | $78,057 | $6,505 |
| Azathioprine | 13 | $5,664 | $436 |
| Mycophenolate Mofetil | 24 | $3,382 | $141 |
| Febuxostat | 15 | $3,117 | $208 |
| Leflunomide | 43 | $3,100 | $72 |
| Methotrexate | 85 | $2,826 | $33 |
| Hydroxychloroquine Sulfate | 50 | $2,321 | $46 |
| Colchicine | 16 | $1,505 | $94 |
| Prednisone | 94 | $1,072 | $11 |
| Methotrexate | 16 | $317 | $20 |
| Allopurinol | 27 | $290 | $11 |
| Amitriptyline | 12 | $245 | $20 |
| Duloxetine | 13 | $191 | $15 |
| Methylprednisolone | 12 | $141 | $12 |
2022: 15 drugs
| Xeljanz | 30 | $193,262 | $6,442 |
| Cimzia | 15 | $131,226 | $8,748 |
| Humira | 15 | $102,566 | $6,838 |
| Hydroxychloroquine Sulfate | 64 | $4,119 | $64 |
| Methotrexate | 88 | $4,118 | $47 |
| Mycophenolate Mofetil | 24 | $3,625 | $151 |
| Colchicine | 19 | $2,518 | $133 |
| Febuxostat | 12 | $2,082 | $174 |
| Leflunomide | 23 | $1,943 | $84 |
| Prednisone | 90 | $1,361 | $15 |
| Allopurinol | 30 | $467 | $16 |
| Methotrexate | 22 | $425 | $19 |
| Amitriptyline | 24 | $311 | $13 |
| Duloxetine | 19 | $253 | $13 |
| Methylprednisolone | 16 | $106 | $7 |
2021: 16 drugs
| Xeljanz | 31 | $179,173 | $5,780 |
| Cimzia | 16 | $114,810 | $7,176 |
| Hydroxychloroquine Sulfate | 62 | $6,259 | $101 |
| Methotrexate | 98 | $4,667 | $48 |
| Leflunomide | 32 | $3,877 | $121 |
| Colchicine | 13 | $2,730 | $210 |
| Mycophenolate Mofetil | 20 | $2,267 | $113 |
| Prednisone | 89 | $1,047 | $12 |
| Febuxostat | 14 | $903 | $64 |
| Duloxetine | 32 | $710 | $22 |
| Sulfasalazine Dr | 13 | $582 | $45 |
| Methylprednisolone | 19 | $373 | $20 |
| Methotrexate | 16 | $274 | $17 |
| Amitriptyline | 17 | $217 | $13 |
| Allopurinol | 14 | $168 | $12 |
| Cyclobenzaprine | 12 | $31 | $3 |
2020: 13 drugs
| Xeljanz | 27 | $136,780 | $5,066 |
| Mycophenolate Mofetil | 18 | $7,855 | $436 |
| Hydroxychloroquine Sulfate | 99 | $7,398 | $75 |
| Leflunomide | 36 | $5,099 | $142 |
| Methotrexate | 135 | $4,666 | $35 |
| Diclofenac | 30 | $3,193 | $106 |
| Colchicine | 11 | $1,946 | $177 |
| Prednisone | 78 | $1,082 | $14 |
| Sulfasalazine Dr | 18 | $869 | $48 |
| Duloxetine | 30 | $571 | $19 |
| Methylprednisolone | 18 | $247 | $14 |
| Methotrexate | 14 | $230 | $16 |
| Allopurinol | 13 | $104 | $8 |
2019: 14 drugs
| Xeljanz | 20 | $89,578 | $4,479 |
| Humira | 12 | $61,440 | $5,120 |
| Mycophenolate Mofetil | 27 | $7,707 | $285 |
| Leflunomide | 38 | $5,930 | $156 |
| Hydroxychloroquine Sulfate | 61 | $5,687 | $93 |
| Methotrexate | 119 | $4,418 | $37 |
| Cevimeline | 11 | $2,734 | $249 |
| Diclofenac | 30 | $2,512 | $84 |
| Colchicine | 13 | $1,979 | $152 |
| Prednisone | 88 | $986 | $11 |
| Duloxetine | 21 | $627 | $30 |
| Methotrexate | 19 | $238 | $13 |
| Meloxicam | 15 | $30 | $2 |
| Alendronate | 14 | $25 | $2 |
2018: 12 drugs
| Xeljanz | 15 | $63,016 | $4,201 |
| Leflunomide | 51 | $8,196 | $161 |
| Hydroxychloroquine Sulfate | 70 | $7,160 | $102 |
| Colchicine | 27 | $6,145 | $228 |
| Mycophenolate Mofetil | 26 | $5,575 | $214 |
| Methotrexate | 103 | $4,948 | $48 |
| Voltaren | 13 | $3,264 | $251 |
| Duloxetine | 34 | $891 | $26 |
| Prednisone | 91 | $813 | $9 |
| Methylprednisolone | 14 | $167 | $12 |
| Meloxicam | 23 | $57 | $2 |
| Alendronate | 12 | $20 | $2 |
2017: 16 drugs
| Hydroxychloroquine Sulfate | 49 | $6,281 | $128 |
| Leflunomide | 41 | $6,112 | $149 |
| Methotrexate | 96 | $4,978 | $52 |
| Colcrys | 16 | $4,703 | $294 |
| Colchicine | 18 | $3,569 | $198 |
| Diclofenac | 12 | $1,213 | $101 |
| Duloxetine | 40 | $934 | $23 |
| Prednisone | 88 | $889 | $10 |
| Sulfasalazine Dr | 16 | $776 | $48 |
| Sulfasalazine | 18 | $387 | $21 |
| Methylprednisolone | 12 | $222 | $18 |
| Allopurinol | 12 | $172 | $14 |
| Methotrexate | 12 | $148 | $12 |
| Meloxicam | 25 | $72 | $3 |
| Cyclobenzaprine | 14 | $25 | $2 |
| Alendronate | 12 | $19 | $2 |
2016: 11 drugs
| Hydroxychloroquine Sulfate | 71 | $9,705 | $137 |
| Leflunomide | 15 | $3,069 | $205 |
| Methotrexate | 76 | $2,761 | $36 |
| Duloxetine | 42 | $1,990 | $47 |
| Diclofenac | 12 | $1,802 | $150 |
| Prednisone | 65 | $1,104 | $17 |
| Mycophenolate Mofetil | 11 | $904 | $82 |
| Sulfasalazine | 14 | $400 | $29 |
| Allopurinol | 14 | $222 | $16 |
| Sulfasalazine Dr | 11 | $187 | $17 |
| Sulfamethoxazole-Trimethoprim | 14 | $46 | $3 |
2015: 4 drugs
| Methotrexate | 37 | $2,518 | $68 |
| Hydroxychloroquine Sulfate | 13 | $1,653 | $127 |
| Duloxetine | 17 | $991 | $58 |
| Prednisone | 22 | $418 | $19 |
2014: 15 drugs
| Methotrexate | 111 | $10,827 | $98 |
| Duloxetine | 47 | $7,942 | $169 |
| Colcrys | 20 | $5,245 | $262 |
| Mycophenolate Mofetil | 23 | $4,061 | $177 |
| Voltaren | 30 | $3,832 | $128 |
| Hydroxychloroquine Sulfate | 84 | $3,417 | $41 |
| Celebrex | 12 | $3,340 | $278 |
| Azulfidine | 14 | $1,990 | $142 |
| Leflunomide | 34 | $1,468 | $43 |
| Prednisone | 86 | $1,154 | $13 |
| Hydrocodone-Acetaminophen | 38 | $881 | $23 |
| Methylprednisolone | 20 | $545 | $27 |
| Methotrexate | 18 | $290 | $16 |
| Latanoprost | 17 | $256 | $15 |
| Meloxicam | 19 | $138 | $7 |
2013: 18 drugs
| Cymbalta | 60 | $17,721 | $295 |
| Methotrexate | 127 | $9,752 | $77 |
| Colcrys | 37 | $6,093 | $165 |
| Lyrica | 18 | $4,384 | $244 |
| Hydroxychloroquine Sulfate | 114 | $3,900 | $34 |
| Celebrex | 16 | $3,333 | $208 |
| Mycophenolate Mofetil | 23 | $2,793 | $121 |
| Leflunomide | 52 | $2,035 | $39 |
| Hydrocodone-Acetaminophen | 70 | $1,825 | $26 |
| Prednisone | 93 | $940 | $10 |
| Methylprednisolone | 26 | $756 | $29 |
| Sulfasalazine | 13 | $517 | $40 |
| Atorvastatin | 12 | $462 | $39 |
| Dapsone | 11 | $441 | $40 |
| Meloxicam | 36 | $379 | $11 |
| Tramadol | 16 | $244 | $15 |
| Methocarbamol | 11 | $150 | $14 |
| Allopurinol | 20 | $125 | $6 |
Money from drug and device companies
$50 in 2023
| 2023 | 1 | 1 | None | $50 |
| 2022 | 1 | 1 | None | $82 |
| 2019 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AbbVie | Rinvoq | $50 | 1 payment
|
See the published payment
| AbbVie | Meals · 2023-04-01 | Rinvoq | $50 |
See earlier years (2022, 2019)
2022: $82
| Aurinia Pharma U.S. | Lupkynis | $82 | 1 payment
|
2019: $20
| Otsuka America Pharmaceutical | Rexulti | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1144227182
- Licence
- CA A77436, IL 036.119828California A77436: Current · expires 2028-09-30Illinois 036119828: Not Renewed
- Trained
- University of Florida College of Medicine, 1999
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2005-07-06
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1000 Welch Rd, Palo Alto, CA, 94304 · 900 Blake Wilbur Dr, Palo Alto, CA, 94304